ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |